← Leaderboards
Richard M Terek
Rhode Island Hospital
$4,358,371
Attributed
$4,670,262
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $656.6K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,670,262 · 7
By mechanism
R01$3,319,038 · 2
P20$1,351,224 · 5
Top collaborators
- Jack R Wands1 shared
Most similar at Rhode Island Hospital
Same institution · by research overlap
- Lei Wei$1,759,645
- Jack R Wands$15,823,895
- Qian Chen$25,602,425
- Angie Guan$73,728
Others in their field
Top investigators on “Chondrosarcoma”
- Benjamin Aaron Alman · Duke University$3,704,350
- Constance E Brinckerhoff · Dartmouth College$3,603,343
- Christal Dyane Sohl · Yale University$2,354,104
- Sean P Scully · Duke University$2,112,875
- Christian Michael Metallo · University Of California, San Diego$1,608,125
- Motomi Enomoto-Iwamoto · Thomas Jefferson University$1,517,313
Research focus
ChondrosarcomaMetastatic Neoplasm To The LungGrowthSignal TransductionVascular Endothelial Growth FactorsTumorMolecular TargetPathway InteractionsCytotoxic ChemotherapyMolecularMediatingCellsBaseBone NeoplasmsHypoxiaAngiogenesisResistanceNeoplastic CellMalignant Bone NeoplasmMalignant NeoplasmsCancer TherapyLinkEffectivenessIn Vivo
Grant awards (13)
ASPH Targeted Therapy for Chondrosarcoma$656,612
R01 · FY2025 · CA · contact PI
ASPH Targeted Therapy for Chondrosarcoma$623,782
R01 · FY2024 · CA · contact PI
ASPH Targeted Therapy for Chondrosarcoma$638,644
R01 · FY2023 · CA · contact PI
Targeting CXCR4 and microRNA as Therapy for Chondrosarcoma$280,000
R01 · FY2017 · CA · contact PI
Targeting CXCR4 and microRNA as Therapy for Chondrosarcoma$280,000
R01 · FY2016 · CA · contact PI
Targeting CXCR4 and microRNA as Therapy for Chondrosarcoma$280,000
R01 · FY2015 · CA · contact PI
Targeting CXCR4 and microRNA as Therapy for Chondrosarcoma$280,000
R01 · FY2014 · CA · contact PI
Targeting CXCR4 and microRNA as Therapy for Chondrosarcoma$280,000
R01 · FY2013 · CA · contact PI
RI COBRE: MECHANISMS OF ANGIOGENESIS IN CHONDROSARCOMA$266,492
P20 · FY2011 · RR · contact PI
RI COBRE: MECHANISMS OF ANGIOGENESIS IN CHONDROSARCOMA$254,778
P20 · FY2010 · RR · contact PI
RI COBRE: MECHANISMS OF ANGIOGENESIS IN CHONDROSARCOMA$200,186
P20 · FY2009 · RR · contact PI
RI COBRE: MECHANISMS OF ANGIOGENESIS IN CHONDROSARCOMA$210,725
P20 · FY2008 · RR · contact PI
RI COBRE: MECHANISMS OF ANGIOGENESIS IN CHONDROSARCOMA$419,043
P20 · FY2007 · RR · contact PI